It can also trigger oxidative stress and inflammatory responses, further facilitating the progression from NAFLD to nonalcoholic steatohepatitis.[14–16] Serum insulin level, as a key compensatory marker of IR, may not only reflect metabolic disorders but also directly contribute to the development and progression of NAFLD.[17,18]. The gene discussed is INS; the disease is Other metabolic disease.